Free Trial
→ INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (From Traders Agency) (Ad)tc pixel Free BNTX Stock Alerts

BioNTech (BNTX) SEC Filings & 10K Form

BioNTech logo
$99.75 +1.48 (+1.51%)
Closing price 09/24/2025 04:00 PM Eastern
Extended Trading
$99.40 -0.35 (-0.35%)
As of 04:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent BioNTech SEC Filings

Export to Excel
DateFilerForm TypeView
09/08/2025
3:40 PM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2025
6:01 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2025
3:41 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2025
5:44 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2025
3:44 PM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2025
7:22 AM		BioNTech (Subject)
Tureci Ozlem (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2025
7:27 AM		BioNTech (Subject)
Medine GmbH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2025
7:43 AM		BioNTech (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
08/11/2025
5:37 AM		BioNTech (Filed by)
CureVac N.V. (Subject)
Form 425
08/11/2025
5:24 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/04/2025
6:57 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/04/2025
7:01 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2025
7:53 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2025
7:32 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
3:40 PM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2025
3:47 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144/A
06/04/2025
7:31 AM		BioNTech (Subject)
Jeggle Helmut Wolfgang (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
6:20 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
8:00 AM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
7:58 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2025
5:14 PM		BioNTech (Subject)
Medine GmbH (Filed by)
Form SCHEDULE 13G/A
05/07/2025
6:30 AM		BioNTech (Subject)
Jeggle Helmut Wolfgang (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
6:33 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2025
5:53 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2025
5:33 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
6:54 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
5:57 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
6:00 AM		BioNTech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/27/2025
6:57 AM		BioNTech (Subject)
Richardson Ryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
6:53 AM		BioNTech (Subject)
Medine GmbH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
6:50 AM		BioNTech (Subject)
Poetting Sierk (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:02 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
5:58 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
6:25 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
6:21 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2024
4:56 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
4:25 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
5:35 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:57 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
4:50 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
5:37 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:06 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:38 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
5:49 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
5:53 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
5:57 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2024
8:04 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
4:03 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
7:41 AM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:15 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:13 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
3:24 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:17 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
4:14 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
5:18 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
7:12 AM		BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
3:52 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2024
4:12 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
6:14 PM		ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BNTX) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
Warren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the Nasdaq
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...
Altimetry | Sponsoredtc pixel
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel